MODIFICATION OF PROCATH ELECTROPHYSIOLOGY CATHETER, EP MEDSYSTEMS ELECTROPHYSIOLOGY CATHETER

K991001 · Ep Medsystems · DRF · Jul 15, 1999 · Cardiovascular

Device Facts

• Record ID: K991001
• Device Name: MODIFICATION OF PROCATH ELECTROPHYSIOLOGY CATHETER, EP MEDSYSTEMS ELECTROPHYSIOLOGY CATHETER
• Applicant: Ep Medsystems
• Product Code: DRF · Cardiovascular
• Decision Date: Jul 15, 1999
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 870.1220
• Device Class: Class 2

Intended Use

ProCath® Electrophysiology (EP or Electrode) Catheters are indicated for temporary use in electrophysiology studies, intracardiac pacing, stimulation, sensing and ECG recording only.

Device Story

ProCath Electrophysiology Catheter is a medical device used for temporary intracardiac procedures. It functions as an electrode catheter to facilitate electrophysiology studies, pacing, stimulation, sensing, and ECG recording. The device is operated by physicians in a clinical or hospital setting. It provides electrical interface with cardiac tissue, allowing the clinician to monitor cardiac signals and deliver pacing stimuli to diagnose or manage cardiac arrhythmias. The modification involves a steering mechanism to improve catheter placement and maneuverability within the heart chambers.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Electrode catheter with steering modification. Designed for intracardiac use. Operates as a passive electrical interface for sensing and stimulation. No active electronic components or software algorithms.

Indications for Use

Indicated for temporary use in electrophysiology studies, intracardiac pacing, stimulation, sensing, and ECG recording in patients requiring cardiac electrophysiological evaluation.

Regulatory Classification

Identification

An electrode recording catheter or an electrode recording probe is a device used to detect an intracardiac electrocardiogram, or to detect cardiac output or left-to-right heart shunts. The device may be unipolar or multipolar for electrocardiogram detection, or may be a platinum-tipped catheter which senses the presence of a special indicator for cardiac output or left-to-right heart shunt determinations.

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, with flowing lines representing hair or movement.

Public Health Service

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

JUL 15 1999

Mr. Joseph C. Griffin, III President ProCath Corporation Cooper Run Executive Park 575 Route 73 North, Bldg. D West Berlin, NJ 08091-9293

Re : K991001 Modification of ProCath Electrophysiology Catheter Requlatory Class: II (two) Product Code: DRF Dated: June 10, 1999 Received: June 18, 1999

Dear Mr. Griffin:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food Drug and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, qood manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 A substantially equivalent determination assumes compliance to 895. with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Requlation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in

{1}------------------------------------------------

regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at [phone]. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, 2 Misbranding by reference to premarket notification? (21CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number [phone] or [phone] or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".

Sincerely yours
Thomas J. Callehan

Thomas J.Callahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

## 510(k) Number (if known): K991001

Device Name: Electrophysiology Catheter (Steering Modification)

Indications for use:

ــــ ــــ ــــ ـــــ ــــــ ـــــ

— —

ProCath® Electrophysiology (EP or Electrode) Catheters are indicated for temporary use in electrophysiology studies, intracardiac pacing, stimulation, sensing and ECG recording only.

## (PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Concurrence of CDRH, Office of Device Evaluation (ODE)

Or K. T. M.

ivision Sign-Off) Division of Cardiovascular, Respiratory, and Neurological Devi

Neurological Devices
510(k) Number K991001

| Prescription Use | V |
|----------------------|---|
| (Per 21 CFR 801.109) | |

OR

Over-The -Counter Use - - -

(Optional Format 1-2-96)